Conceptus to Present at Pacific Growth Equities' 2006 Life Sciences Growth Investor Conference.SAN CARLOS, Calif. -- Headline of release should read: Conceptus conceptus /con·cep·tus/ (-tus) the product of the union of oocyte and spermatozoon at any stage of development from fertilization until birth, including extraembryonic membranes as well as the embryo or fetus. to Present at Pacific Growth Equities' 2006 Life Sciences Growth Investor Conference (sted Conceptus to Present at Pacific Growth Equities' 2005 Life Sciences Growth Investor Conference) The corrected release reads: CONCEPTUS TO PRESENT AT PACIFIC GROWTH EQUITIES' 2006 LIFE SCIENCES GROWTH INVESTOR CONFERENCE Conceptus, Inc. (Nasdaq:CPTS CPTS Certified Penetration Testing Specialist (network security) CPTS Comptroller Squadron CPTS Computer Program Test Specifications CPTS Catastrophe Personnel Tracking System CPTS Claims Procedure Training Specialist ), developer of the non-incisional permanent birth control procedure Essure(R), today announced that Greg Lichtwardt, Conceptus' chief financial officer, will present at Pacific Growth Equities 2006 Life Sciences Growth Conference on Wednesday, June 14, 2006, at 1:30 PM PST PST Paroxysmal supraventricular tachycardia, see there . The conference will be held at the InterContinental Mark Hopkins Hotel in San Francisco from June 12 through June 14, 2006. The conference is an exclusive gathering of leading technology and life science company CEOs and institutional portfolio managers. During the three-day event three-day event a competition in the pleasure horse sport comprising usually one day each for dressage, cross country and show jumping. , investors will have access to over 120 leading public and private companies in technology and life sciences. More information about Pacific Growth Equities Life Sciences Growth Conference can be found at www.pacificgrowth.com. About the Essure Procedure The Essure procedure deploys a soft micro-insert into the fallopian tube fallopian tube (fəlō`pēən), either of a pair of tubes extending from the uterus to the paired ovaries in the human female, also called oviducts, technically known as the uterine tube. through the cervix using a minimally invasive transcervical tubal Tubal (t  `bəl), in the Bible, son of Japheth. access catheter. Once in place, the device is designed to elicit tissue growth in and around the micro-insert to form an occlusion or blockage in the fallopian tube. An Essure procedure does not require cutting or penetrating the abdomen and can be performed in a less costly procedure setting without general anesthesia. A woman is able to return home about 45 minutes after the procedure is completed. There is a three-month waiting period after the procedure during which women must use another form of birth control. The Essure procedure is 99.80% effective after four years of follow-up. The Essure procedure has been demonstrated in a small portion of the women undergoing clinical studies to be 99.74% effective based on 5 years of follow-up. Five year follow-up of all patients in clinical trials is ongoing. About Conceptus Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation ligation /li·ga·tion/ (li-ga´shun) the application of a ligature. tubal ligation sterilization of the female by constricting, severing, or crushing the uterine tubes. , which is currently the leading form of birth control worldwide. The availability of the Essure procedure in the U.S. is expected to open up a market currently occupied by incisional tubal ligation and vasectomy vasectomy, male sterilization by surgical excision of the vas deferens, the thin duct that carries sperm cells from the testicles to the prostate and the penis. , which combined account for over 1 million procedures annually. Additional information about the Essure procedure is available at www.essure.com or by calling the Essure Information Center at 1-877-ESSURE1. Additional information about Conceptus is available at www.conceptus.com or by calling 1-877-ESSURE2. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion